Диссертация (1173234), страница 22
Текст из файла (страница 22)
- 13(2). – с.76-79.124. Эндокринология: национальное руководство / под ред. И. И. Дедова, Г. А.Мельниченко. - 2-е изд., перераб. и доп. - М.: ГЭОТАР-Медиа, 2016. -c.1112.125. Ábrahám, G. The Antihypertensive Efficacy of the Triple Fixed Combinationof Perindopril, Indapamide, and Amlodipine: The Results of the PETRA Study / G.Ábrahám, C.A. Dézs, G. Ábrahám [et al.] //Advances in Therapy.
- 2017. – V.34, №7.– р.1753 - 1763.126. ADVANCE Collaborative Group. Effects of a fixed combination of perindopriland indapamide on macrovascular and microvascular outcomes in patients with type 2diabetes mellitus (the ADVANCE trial): a randomized controlled trial // Lancet. —2007. — Vol.370. — р.829-840.127. Agnoletti, D. Central hemodynamic modifications in diabetes mellitus / D.Agnoletti, A.
Lieber, Y. Zhang [ et al.] // Atherosclerosis. – 2013. – 230(2). – р.315321.128. AlGhatrif, M. The conundrum of arterial stiffness, elevated blood pressure, andaging / M. AlGhatrif, E.G. Lakatta / Curr Hypertens Rep. – 2015. – 17. - р.1-9.129.
AlGhatrif, M. Longitudinal trajectories of arterial stiffness and the role of bloodpressure: the Baltimore Longitu- dinal Study of Aging / M. AlGhatrif, J.B. Strait, C.H.Morrell [et al.] // Hypertension. - 2013. - 62. – р.934-941.130. Alvim, R. O. Impact of diabetes mellitus on arterial stiffness in a representativesample of an urban Brazilian population / R. O. Alvim, P. C. Santos, M. M.
Musso [ etal.] // Diabetol Metab Syndr. – 2013. – V5(45). – р.1-8.131. Andreeva, L. Arterial hypertension and metabolic syndrome: focus on circadianprofile of central aortic pressure and arterial stiffness / L. Andreeva, L. Panchenkova, K.Khamidova // The 33rd congress of internal medicine WCIM Bali 2016. - р.597.133132. Andreeva, L. Central aortic pressure and arterial stiffness assessment using 24hour ambulatory monitoring in hypertensive subjects with metabolic syndrome andhypothyroidism / L. Andreeva, L. Panchenkova, K.
Khamidova // Journal ofHypertension. 2016. - V.34. - е-161-е-162. Suppl. 1: Joint meeting 26-th HypertensionSeoul 2016, South Korea, Seoul, 2016.133. Andreeva, L. Influence of metabolic syndrome on course of arterial hypertensionwith the position of evolution the central aortic pressure and arterial stiffness / L.Andreeva, A. Martynov L., Panchenkova [et al.] // 2nd Prague European Days of InternalMedicine.- Prague, Chech Republic, 2016. - р.19.134.
Andreeva, L. The clinical significance “Pulse Time Index of Norm” as a markerof target organ damage / L. Andreeva, A. Martynov L., Panchenkova [et al.] // ESCCongress Barcelona - 2017. - European Heart Journal. – 2017. – Suppl. 38. – 759.135. Arnett, D. K. Hypertension and arterial stiffness: The atherosclerosisrisk in communities study / D. K. Arnett, Boland, L. L.
Evans, W. Gregory [et al.] // AmericanJournal of Hypertension. – 2000. – р.317-323.136. Asmar, R. Pulse wave velocity as endpoint in large-scale intervention trial, TheComplior study. Scientific, Quality control, Coordination and Investigation Committesof the Complior Study / R. Asmar, J. Topouchian, B. Pannier [et al.] // J Hypertension. –2001.
– 19. – р.813-818.137. Asmar, R. Pulse pressure and aortic pulse wave are markers of cardiovascular riskin hypertensive populations / R. Asmar, A. Rudnichi, I. Blacher et al // Am J Hypertens.— 2001. ― 14(2). ― р.91-97.138. Asvold, B.O. Thyroid function and the risk of coronary heart disease: 12-yearfollow-up of the HUNT Study in Norway / B.O.
Asvold, T. Bjоro, C. Platou [et al.] //Clin. Endocrinol. (Oxf.). – 2012. - 77(6). – р.911–917.139. Aydoğan, Y. An assessment of the relationship between thyroid nodulecharacteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter / Y.Aydoğan, M. Altay, O. Ünsal [et al.] // Endocrine.
– 2018. – V.62. – p.440-447.140. Badhwar, S. Regional arterial stiffness in central and peripheral arteries isdifferentially related to endothelial dysfunction assessed by brachial flow-mediated134dilation in metabolic syndrome / S. Badhwar, D.S. Chandran, A.K. Jaryal [et al.] //Diab Vasc Dis Res.- 2018. – V.15(2). – р.106-113.141. Baguet,J.P.Updated Meta-AnalyticalApproachtotheEfficacyofAntihypertensive Drugs in Reducing Blood Pressure / J.P. Baguet, B.
Legallicier, S.Robitail // Clin Drug Invest. – 2007. - 27(11). – р.734–752.142. Baloch, Z. Laboratory medicine practice guidelines. Laboratory support for thediagnosis and monitoring of thyroid disease / Z. Baloch, P. Carayon, B. Conte-Devolx[et al.] // Thyroid. 2003. - 13(1). – р.3–126.143. Beckett, N.S. HYVET Study Group Treatment of hypertension in patients 80years of age or older / N.S. Beckett, R. Peters, A.E. Fletcher [et al.] // N Engl J Med. –2008. – 358.
– р.1887-1898.144. Benetos, A. Mortality and cardiovascular events are best predicted by lowcentral/peripheral pulse pressure amplification but not by high blood pressure levels inelderly nursing home subjects. The PARTAGE study / A. Benetos, S.Gautier, C.Labat // J Am Coll Cardiol. – 2012. – V.60. – р.1503–1511.145. Bielecka-Dabrowa.
Subclinical hypothyroidism and the development of heartfailure: an overview of risk and effects on cardiac function / Bielecka-Dabrowa,B. Godoy, T. Suzki, M. Banach, S. von Haehling // A Clin Res Cardiol. – 2018. –V.107(2). – p.1-9.146. Biondi, B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction /В. Biondi // European J. of Endocrinol. – 2012. - 167(5).
–р.609–18.147. Biondi, B. T he 2015 European Thyroid Association Guidelines on Diagnosis andTreatment of Endogenous Subclinical Hyperthyroidism / B. Biondi // Eur Thyroid J. –2015. – 4. - 149–163.148. Boggio, А. Is thyroid-stimulating hormone within the normal reference range arisk factor for atherosclerosis in women? / A. Boggio, U. Muzio, M. Fiscella [ et al.] //Intern Emerg Med. – 2014. – V9(1). – р.51-57.149.
Boutouyrie, P. Amlodipine-valsartan combination decreases central systolicblood pressure more effectively than the amlodipine-atenolol combination: the135EXPLOR study / P. Boutouyrie, A. Achouba, P. Trunet [et al.] // Hypertension. – 2010.– 55. – р.1314–1322.150. Bray, G.A. Overweight and obesity: the pathogenesis of cardiometabolic risk /G.A. Bray, M.B. Clearfield, D.J. Fintel // Clin. Cornestrone. – 2009. - 9(4). – р.30–40;discussion 41–42.151. Brenta, G.
Diabetes and thyroid disorders / G. Brenta // Thyroid. International. —Vasc Dis. – 2010. - V.10(4). – p.172-177.152. Cabral, M.D. Normal flow-mediated vasodilatation of the brachial artery andcarotid artery intima-media thickness in subclinical hypothyroidism / M.D. Cabral, P.F.Teixeira, N.A. Silva [et al.] // Braz J Med Biol Res.
– 2009. – 42. – p.426–432.153. Chen, L. The association of metabolic syndrome and its components withbrachial-ankle pulse wave velocity in south China / L. Chen, W. Zhu, L. Mai [et al.] //Atherosclerosis. – 2015. – V.240(2). – р.345-350.154. Chen, C.H. Different effects of fosinopril and atenolol on wave reflections inhypertensive patients / C.H. Chen, C.T. Ting, S.J. Lin [et al.] // Hypertension 1995. –25.
– р.1034–1041.155. Cheng, H.M. Measurement accuracy of a stand-alone oscillometric central bloodpressure monitor: a validation report for Microlife WatchBP Office Central / H.M.Cheng, S.H. Sung, Y.T. Shih [et al.] / Am J Hypertens. – 2013. - 26(1). – р.42–50.156. Dagre, A.G.
Arterial stiffness is increased in subjects with hypothyroidism / A.G.Dagre, J. P. Lekakis, T. G. Papaioannou [et al.] // International Journal of Cardiology. 2005. - V.103. - р.1–6.157. Dangardt, F. Increased rate of arterial stiffening with obesity in adolescents: afive-year follow-up study / F. Dangardt, Y. Chen, K. Berggren [et al.] // PLoS One. –2013. - 8:e57454.158. David, Z.I.
Effect of Direct Renin Inhibition on Renal Hemodynamic Function,Arterial Stiffness, and Endothelial Function in Humans With Uncomplicated Type 1Diabetes. A pilot study / Z.I. David, M.D. Cherney, R.N. Vesta Lai [et al.] // DiabetesCare. – 2010. - 33(2). – р.361-365.136159. Deicher, R. Homocysteine: a risk factor for cardiovascular disease in subclinicalhypothyroidism? / R. Deicher, H. Vierhapper // Thyroid. – 2002. - 12(8).